Troy Tazbaz, CDRH digital health leader, resigns
Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading key policies on artificial ...
FierceBiotech5d
FDA digital director Troy Tazbaz departs the agency
The head of the FDA’s artificial-intelligence-focused Digital Center of Excellence, Troy Tazbaz, is departing the agency ...
BioPharma Dive5d
Troy Tazbaz, an FDA digital health leader, resigns
Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading on policies involving artificial ...
JD Supra2d
How New Executive Orders May Affect FDA’s Medical Device Operations
Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...
GlobalData on MSN6d
FDA issues cybersecurity risk alert over Contec patient monitor
The FDA says the cybersecurity vulnerabilities identified may put patients at risk when the device is connected to the ...
manilatimes2d
Transparency Notifications from Shareholders
(1) The total number of outstanding shares of the Company on 24 January 2025 mentioned in the relevant transparency notifications amounts to 52,416,601, each share giving right to one (1) vote (being ...
pharmaphorum3d
FDA competition seeks digital endpoints for Parkinson’s
The competition – on which more details are available here – is being run by the FDA’s Center for Devices and Radiological Health (CDRH) and the Office of Digital, and ties in with ongoing ...
pharmaphorum4d
Google gives ex-FDA digital health head Bakul Patel strategic role
He was also involved in the creation of the FDA's Digital Health Center of Excellence in 2020 and drawing up the Center for Devices and Radiological Health (CDRH) 2022-2025 strategic priorities ...
medtechdive5d
FDA warns about patient monitor cybersecurity vulnerabilities
Vulnerabilities in certain Contec and Epsimed patient monitors can allow people to gain access and potentially manipulate the ...
World Bank2d
Drug-Resistant Infections: A Threat to Our Economic Future
Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...